bioRxivCell BiologyPreprint
TCF4 and CtBP1 Repress LEF1 to Maintain a TCF4-centric Transcriptional Program in Colon Cancer.
Markus A. BrowniD, Sanam Yaghoubi, Juliane Kamlah, Wei-dong D. CheniD, Darawalee Zong, Sepehr Talebian Khorasani, Tianzuo ZhaniD, Michael BoutrosiD, Jordi CampsiD, Paul S. MeltzeriD
- Citations
- 0
Abstract
Abstract The canonical WNT signaling pathway guides cell growth throughout the human lifespan. In adults, WNT plays an essential role in tissue homeostasis by maintaining tissue stem cells. In the intestine, the WNT transcription factor, TCF4, is necessary for stem cell maintenance. Aberrant activation of WNT signaling is generally accepted as an initiating event in colon cancer, leading to constitutive TCF4 activity. To investigate the role of this key transcription factor in global gene regulation, we abrogated TCF4 expression in colon cancer cells. Loss of TCF4 function resulted in the over-expression of the WNT transcription factor, LEF1. LEF1 was transcriptionally competent and over-compensated for TCF4 (TCF7L2) silencing in a WNT reporter assay. TCF4 enlisted the transcriptional repressor CtBP1, and bound the LEF1 promoter, indicative of direct repression. TCF4 and LEF1 drove different transcriptional programs, with TCF4 favoring MYC and cell cycle progression, while LEF1 favored immune-related gene signatures. TCF4 was the primary regulator of MYC expression, yet also the mediator of LEF1 repression, suggestive of competition centered on TCF4 transcriptional output despite the {beta}-catenin saturated colon cancer nucleus. We conclude that TCF4 has dual activator-repressor activity in colon cancer.
- organism: human
- assay: bulk RNA-seq
- research focus: gene regulatory network inference
- research focus: differential expression
- research focus: cell-cell communication
- approach: statistical model
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TCF7L2 Silencing Reprograms the 4D Nucleome of Colorectal Cancer Cells
M. A. Brown, G. A. Dotson, … T. Ried·bioRxiv·May 12, 2020
- Transcriptional activity mediated by beta-CATENIN and TCF/LEF family members is completely dispensable for survival of multiple human colorectal cancer cell lines
J. Froehlich, K. Rose, A. Hecht·bioRxiv·Dec 5, 2022
- HNF&alpha is a target of the Wnt/beta-catenin pathway and regulates colorectal carcinogenesis
- The fate of secretory cells during intestinal homeostasis, regeneration, and tumor formation is regulated by Tcf4
Lucie Janečková, Monika Šťastná, … Vladimír Kořínek·bioRxiv·Jul 11, 2024
- Differential Wnt/β-Catenin Signaling via TCF7L2/LEF1 Binding Specificity Shapes Cellular and Tumor Phenotypes
Thomas A. Kluiver, Anna Nordin, … Weng Chuan Peng·bioRxiv·Nov 4, 2025
- The oncogene FOXQ1 is a selective activator of Wnt/β-catenin signalling
Giulia Pizzolato, Lavanya Moparthi, … Stefan Koch·bioRxiv·Jan 17, 2022